LMR Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-71,984
Closed -$6.69M 1416
2021
Q4
$6.69M Buy
+71,984
New +$4.74M 0.07% 209

LMR Partners's ARNA Position: Q1 2022 in Review

LMR Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 71,984 shares — an estimated $6.69M sold.

LMR Partners first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $6.69M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • LMR Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • LMR Partners sold 71,984 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $6.69M.
  • LMR Partners first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • LMR Partners's Arena Pharmaceuticals Inc position peaked at $6.69M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on LMR Partners's 13F filing for Q1 2022, filed 16 May 2022.